(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone has been researched along with s-777469 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buzard, DJ; Han, S; Jones, RM; Thatte, J | 1 |
| Barczyk, A; Baudelet, D; Body-Malapel, M; Carato, P; Djouina, M; Heloire, VM; Leleu-Chavain, N; Millet, R; Renault, N; Rocha, DE | 1 |
1 review(s) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and s-777469
| Article | Year |
|---|---|
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity | 2013 |
1 other study(ies) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and s-777469
| Article | Year |
|---|---|
Benzo[d]thiazol-2(3H)-ones as new potent selective CB
Topics: Anti-Inflammatory Agents; Benzothiazoles; Cannabinoid Receptor Agonists; Colon; Humans; Inflammation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2019 |